Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Multiple cyclophilins involved in different cellular pathways mediate HCV replication.

Gaither LA, Borawski J, Anderson LJ, Balabanis KA, Devay P, Joberty G, Rau C, Schirle M, Bouwmeester T, Mickanin C, Zhao S, Vickers C, Lee L, Deng G, Baryza J, Fujimoto RA, Lin K, Compton T, Wiedmann B.

Virology. 2010 Feb 5;397(1):43-55. doi: 10.1016/j.virol.2009.10.043. Epub 2009 Nov 24.

3.

Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.

Goto K, Watashi K, Inoue D, Hijikata M, Shimotohno K.

Cancer Sci. 2009 Oct;100(10):1943-50. doi: 10.1111/j.1349-7006.2009.01263.x. Epub 2009 Jun 26.

4.

Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H.

J Virol. 2008 Jun;82(11):5269-78. doi: 10.1128/JVI.02614-07. Epub 2008 Apr 2.

5.

Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811.

Goto K, Watashi K, Murata T, Hishiki T, Hijikata M, Shimotohno K.

Biochem Biophys Res Commun. 2006 May 12;343(3):879-84. Epub 2006 Mar 29.

PMID:
16564500
6.

Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.

Phillips S, Chokshi S, Chatterji U, Riva A, Bobardt M, Williams R, Gallay P, Naoumov NV.

Gastroenterology. 2015 Feb;148(2):403-14.e7. doi: 10.1053/j.gastro.2014.10.004. Epub 2014 Oct 8.

PMID:
25305505
7.

Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus.

Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y.

Lab Invest. 2000 Sep;80(9):1373-83.

PMID:
11005206
8.

The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.

Chatterji U, Bobardt M, Selvarajah S, Yang F, Tang H, Sakamoto N, Vuagniaux G, Parkinson T, Gallay P.

J Biol Chem. 2009 Jun 19;284(25):16998-7005. doi: 10.1074/jbc.M109.007625. Epub 2009 Apr 20.

9.

Cyclophilin A and nuclear factor of activated T cells are essential in cyclosporine-mediated suppression of polyomavirus BK replication.

Li YJ, Wu HH, Weng CH, Chen YC, Hung CC, Yang CW, Wang RY, Sakamoto N, Tian YC.

Am J Transplant. 2012 Sep;12(9):2348-62. doi: 10.1111/j.1600-6143.2012.04116.x. Epub 2012 May 29.

10.

Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.

Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, Janssen HL, Metselaar HJ, Peppelenbosch MP, Pan Q.

Gastroenterology. 2014 Jun;146(7):1775-83. doi: 10.1053/j.gastro.2014.02.036. Epub 2014 Feb 26.

PMID:
24582714
11.

Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways.

Liu X, Zhao Z, Li Z, Xu C, Sun L, Chen J, Liu W.

PLoS One. 2012;7(5):e37277. doi: 10.1371/journal.pone.0037277. Epub 2012 May 15.

12.

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.

Carbajo-Lozoya J, Ma-Lauer Y, Malešević M, Theuerkorn M, Kahlert V, Prell E, von Brunn B, Muth D, Baumert TF, Drosten C, Fischer G, von Brunn A.

Virus Res. 2014 May 12;184:44-53. doi: 10.1016/j.virusres.2014.02.010. Epub 2014 Feb 22.

PMID:
24566223
13.

Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis.

Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL.

Liver Int. 2010 Jul;30(6):871-7. doi: 10.1111/j.1478-3231.2010.02257.x. Epub 2010 May 14.

PMID:
20492501
14.

The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts.

Lembo D, Gribaudo G, Riera L, Mondo A, Cavallo R, Angeretti A, Landolfo S.

Antiviral Res. 2000 Aug;47(2):111-20.

PMID:
10996399
15.

Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis.

de Wilde AH, Li Y, van der Meer Y, Vuagniaux G, Lysek R, Fang Y, Snijder EJ, van Hemert MJ.

J Virol. 2013 Feb;87(3):1454-64. doi: 10.1128/JVI.02078-12. Epub 2012 Nov 14.

16.

Latent infection of mouse cells with human cytomegalovirus.

Boldogh I, Gönczöl E, Gärtner L, Vaczi L, Michelson S.

Bull Cancer. 1976 Jul-Sep;63(3):411-6.

PMID:
187270
17.

NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon.

Ma S, Boerner JE, TiongYip C, Weidmann B, Ryder NS, Cooreman MP, Lin K.

Antimicrob Agents Chemother. 2006 Sep;50(9):2976-82.

18.

Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein.

Qing M, Yang F, Zhang B, Zou G, Robida JM, Yuan Z, Tang H, Shi PY.

Antimicrob Agents Chemother. 2009 Aug;53(8):3226-35. doi: 10.1128/AAC.00189-09. Epub 2009 May 18.

19.

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.

Matsuoka S, Dam E, Lecossier D, Clavel F, Hance AJ.

Retrovirology. 2009 Mar 2;6:21. doi: 10.1186/1742-4690-6-21.

20.

Treating hepatitis C: can you teach old dogs new tricks?

Rice CM, You S.

Hepatology. 2005 Dec;42(6):1455-8.

PMID:
16317665

Supplemental Content

Support Center